Dr. Anthony Fauci texted health officials about a theoretical miscarriage risk from fever after the second mRNA dose in ...

In a somewhat surprise announcement, the Food and Drug Administration (FDA) has approved the first US influenza vaccine built ...

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

Experts say messenger RNA (mRNA) vaccines do not alter DNA, contrary to social media posts that resurfaced the long-debunked ...

The mRNA flu shot does the same, but starts with a synthetic process. Lab-produced messenger RNA instructs cells in the body ...

Oncology researchers are actively exploring ways to expand mRNA platforms and develop potential universal cancer vaccines.

The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...

The vaccine, called mFLUSIVA, is expected to be a versatile new option for people seeking protection from influenza and an important step forward for the widespread adoption of mRNA technology.

The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight ...

Approval is only for people 50 years or older ...

A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...

Scientists at the Center for Molecular Medicine Cologne (CMMC) and the CECAD Cluster of Excellence on Aging Research have demonstrated in a biomedical study that ribosomes, the protein factories of ...